Symbol:
Fn3k
Name:
fructosamine 3 kinase
RGD ID:
1559983
Description:
Predicted to enable protein-fructosamine 3-kinase activity. Predicted to be involved in epithelial cell differentiation; fructosamine metabolic process; and peptidyl-lysine deglycation. Predicted to be located in mitochondrion. Predicted to be active in cytosol. Orthologous to human FN3K (fructosamine 3 kinase); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 3-chloropropane-1,2-diol.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
Fnsk; fructosamine 3-kinase; fructosamine-3-kinase; similar to fructosamine-3-kinase
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 107,198,566 - 107,214,176 (+) NCBI GRCr8 mRatBN7.2 10 106,700,670 - 106,715,903 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 106,700,670 - 106,715,895 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 111,803,227 - 111,818,592 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 111,266,283 - 111,281,648 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 106,621,074 - 106,636,294 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 110,626,462 - 110,642,262 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 110,631,494 - 110,642,260 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 110,212,251 - 110,227,799 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 110,664,291 - 110,674,692 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 10 105,166,933 - 105,251,709 (+) NCBI Celera Cytogenetic Map 10 q32.3 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Fn3k Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FN3K mRNA] CTD PMID:31150632 Fn3k Rat 1,1-dichloroethene decreases expression ISO Fn3k (Mus musculus) 6480464 vinylidene chloride results in decreased expression of FN3K mRNA CTD PMID:26682919 Fn3k Rat 1,2-dichloroethane decreases expression ISO Fn3k (Mus musculus) 6480464 ethylene dichloride results in decreased expression of FN3K mRNA CTD PMID:28960355 Fn3k Rat 1,2-dimethylhydrazine decreases expression ISO Fn3k (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FN3K mRNA CTD PMID:22206623 Fn3k Rat 17beta-estradiol decreases expression ISO Fn3k (Mus musculus) 6480464 Estradiol results in decreased expression of FN3K mRNA CTD PMID:19484750 and PMID:39298647 Fn3k Rat 17beta-estradiol multiple interactions ISO FN3K (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of FN3K mRNA CTD PMID:30165855 Fn3k Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO FN3K (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Fn3k Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fn3k (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FN3K mRNA CTD PMID:19770486 Fn3k Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FN3K mRNA CTD PMID:21215274 Fn3k Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fn3k (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FN3K mRNA CTD PMID:21570461 Fn3k Rat 2,4,6-tribromophenol decreases expression ISO FN3K (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Fn3k Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Fn3k (Mus musculus) 6480464 3 more ... CTD PMID:19467301 Fn3k Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO FN3K (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of FN3K protein CTD PMID:31675489 Fn3k Rat 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of FN3K protein CTD PMID:34915118 Fn3k Rat 4,4'-sulfonyldiphenol decreases expression ISO Fn3k (Mus musculus) 6480464 bisphenol S results in decreased expression of FN3K mRNA CTD PMID:39298647 Fn3k Rat 4-hydroxyphenyl retinamide increases expression ISO Fn3k (Mus musculus) 6480464 Fenretinide results in increased expression of FN3K mRNA CTD PMID:28973697 Fn3k Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FN3K mRNA CTD PMID:30047161 Fn3k Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FN3K mRNA CTD PMID:31881176 Fn3k Rat aflatoxin B1 decreases expression ISO Fn3k (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of FN3K mRNA CTD PMID:19770486 Fn3k Rat aflatoxin B1 decreases expression ISO FN3K (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of FN3K mRNA CTD PMID:32234424 Fn3k Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FN3K mRNA CTD PMID:35163327 Fn3k Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of FN3K mRNA CTD PMID:30047161 Fn3k Rat aristolochic acid A increases expression ISO FN3K (Homo sapiens) 6480464 aristolochic acid I results in increased expression of FN3K mRNA CTD PMID:33212167 Fn3k Rat arsenite(3-) increases expression ISO Fn3k (Mus musculus) 6480464 arsenite results in increased expression of FN3K protein CTD PMID:37955338 Fn3k Rat benzo[a]pyrene increases methylation ISO FN3K (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FN3K promoter CTD PMID:27901495 Fn3k Rat benzo[a]pyrene decreases expression ISO FN3K (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FN3K mRNA CTD PMID:32234424 Fn3k Rat Benzo[k]fluoranthene decreases expression ISO Fn3k (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of FN3K mRNA CTD PMID:26377693 Fn3k Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FN3K mRNA CTD PMID:25181051 Fn3k Rat bisphenol A decreases expression ISO Fn3k (Mus musculus) 6480464 bisphenol A results in decreased expression of FN3K mRNA CTD PMID:35598803 Fn3k Rat bisphenol A decreases expression ISO FN3K (Homo sapiens) 6480464 bisphenol A results in decreased expression of FN3K protein CTD PMID:31675489 Fn3k Rat bisphenol A increases expression ISO Fn3k (Mus musculus) 6480464 bisphenol A results in increased expression of FN3K mRNA CTD PMID:33221593 Fn3k Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FN3K mRNA CTD PMID:32145629 Fn3k Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of FN3K gene CTD PMID:28505145 Fn3k Rat cadmium atom increases expression ISO FN3K (Homo sapiens) 6480464 Cadmium results in increased expression of FN3K mRNA CTD PMID:24376830 Fn3k Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FN3K mRNA CTD PMID:25993096 Fn3k Rat carbon nanotube decreases expression ISO Fn3k (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Fn3k Rat chlorpyrifos increases expression ISO Fn3k (Mus musculus) 6480464 Chlorpyrifos results in increased expression of FN3K mRNA CTD PMID:32715474 Fn3k Rat chlorpyrifos decreases expression ISO Fn3k (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of FN3K mRNA CTD PMID:37019170 Fn3k Rat cisplatin decreases expression ISO FN3K (Homo sapiens) 6480464 Cisplatin results in decreased expression of FN3K mRNA CTD PMID:27392435 Fn3k Rat clofibrate decreases expression ISO Fn3k (Mus musculus) 6480464 Clofibrate results in decreased expression of FN3K mRNA CTD PMID:23811191 Fn3k Rat cobalt atom multiple interactions EXP 6480464 [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FN3K mRNA CTD PMID:26577399 Fn3k Rat decabromodiphenyl ether increases expression ISO FN3K (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of FN3K protein CTD PMID:31675489 Fn3k Rat diquat decreases expression ISO Fn3k (Mus musculus) 6480464 Diquat results in decreased expression of FN3K protein CTD PMID:36851058 Fn3k Rat ethanol affects expression ISO Fn3k (Mus musculus) 6480464 Ethanol affects the expression of FN3K mRNA CTD PMID:30319688 Fn3k Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of FN3K mRNA CTD PMID:24793618 Fn3k Rat furan increases expression EXP 6480464 furan results in increased expression of FN3K mRNA CTD PMID:25539665 Fn3k Rat glycidyl methacrylate decreases expression ISO FN3K (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of FN3K protein CTD PMID:36641056 Fn3k Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of FN3K mRNA CTD PMID:21396975 Fn3k Rat iron atom multiple interactions EXP 6480464 [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat iron(0) multiple interactions EXP 6480464 [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat ketamine increases expression EXP 6480464 Ketamine results in increased expression of FN3K mRNA CTD PMID:20080153 Fn3k Rat leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of FN3K mRNA CTD PMID:24136188 Fn3k Rat lipopolysaccharide multiple interactions ISO FN3K (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FN3K mRNA CTD PMID:35811015 Fn3k Rat lipopolysaccharide decreases expression ISO FN3K (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of FN3K mRNA CTD PMID:35811015 Fn3k Rat mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of FN3K mRNA CTD PMID:16507785 Fn3k Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of FN3K mRNA CTD PMID:30047161 Fn3k Rat N-nitrosodiethylamine decreases expression ISO Fn3k (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of FN3K mRNA CTD PMID:24535843 Fn3k Rat N-Nitrosopyrrolidine decreases expression ISO FN3K (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of FN3K mRNA CTD PMID:32234424 Fn3k Rat nickel atom multiple interactions EXP 6480464 [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of FN3K mRNA and [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FN3K mRNA CTD PMID:33484710 Fn3k Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FN3K mRNA CTD PMID:25729387 Fn3k Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of FN3K mRNA CTD PMID:25729387 Fn3k Rat ozone multiple interactions ISO Fn3k (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FN3K mRNA CTD PMID:34911549 Fn3k Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of FN3K mRNA CTD PMID:27638505 Fn3k Rat paracetamol affects expression ISO Fn3k (Mus musculus) 6480464 Acetaminophen affects the expression of FN3K mRNA CTD PMID:17562736 Fn3k Rat paracetamol decreases expression ISO FN3K (Homo sapiens) 6480464 Acetaminophen results in decreased expression of FN3K mRNA CTD PMID:29067470 Fn3k Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of FN3K mRNA CTD PMID:32680482 Fn3k Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FN3K mRNA CTD PMID:35163327 Fn3k Rat permethrin decreases expression ISO Fn3k (Mus musculus) 6480464 Permethrin results in decreased expression of FN3K mRNA CTD PMID:30629241 Fn3k Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FN3K mRNA CTD PMID:19162173 Fn3k Rat pirinixic acid decreases expression ISO Fn3k (Mus musculus) 6480464 pirinixic acid results in decreased expression of FN3K mRNA CTD PMID:23811191 Fn3k Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Fn3k (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of FN3K mRNA CTD PMID:28903501 Fn3k Rat propanal decreases expression ISO FN3K (Homo sapiens) 6480464 propionaldehyde results in decreased expression of FN3K mRNA CTD PMID:26079696 Fn3k Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO FN3K (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FN3K mRNA CTD PMID:35811015 Fn3k Rat silicon dioxide decreases expression ISO Fn3k (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of FN3K mRNA CTD PMID:23221170 Fn3k Rat sodium tungstate increases expression EXP 6480464 sodium tungstate(VI) results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of FN3K mRNA CTD PMID:19281266 Fn3k Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of FN3K mRNA CTD PMID:30047161 Fn3k Rat sunitinib increases expression ISO FN3K (Homo sapiens) 6480464 Sunitinib results in increased expression of FN3K mRNA CTD PMID:31533062 Fn3k Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FN3K mRNA CTD PMID:31150632 Fn3k Rat tetrachloromethane decreases expression ISO Fn3k (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of FN3K mRNA CTD PMID:31919559 Fn3k Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FN3K mRNA] CTD PMID:31150632 Fn3k Rat tetraphene decreases expression ISO Fn3k (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of FN3K mRNA CTD PMID:26377693 Fn3k Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FN3K mRNA CTD PMID:23411599 and PMID:34492290 Fn3k Rat titanium dioxide decreases expression ISO Fn3k (Mus musculus) 6480464 titanium dioxide results in decreased expression of FN3K mRNA CTD PMID:23557971 Fn3k Rat titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of FN3K mRNA CTD PMID:30012374 Fn3k Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of FN3K mRNA CTD PMID:25729387 Fn3k Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of FN3K mRNA CTD PMID:25729387 Fn3k Rat trichloroethene decreases expression ISO Fn3k (Mus musculus) 6480464 Trichloroethylene results in decreased expression of FN3K mRNA CTD PMID:25549359 Fn3k Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of FN3K mRNA CTD PMID:33387578 Fn3k Rat trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of FN3K gene CTD PMID:27618143 Fn3k Rat tungsten multiple interactions EXP 6480464 [Tungsten co-treated with Nickel co-treated with Cobalt] results in increased expression of FN3K mRNA and [Tungsten co-treated with Nickel co-treated with Iron] results in increased expression of FN3K mRNA CTD PMID:24619124 Fn3k Rat valproic acid affects expression ISO Fn3k (Mus musculus) 6480464 Valproic Acid affects the expression of FN3K mRNA CTD PMID:17292431 Fn3k Rat valproic acid increases methylation ISO FN3K (Homo sapiens) 6480464 Valproic Acid results in increased methylation of FN3K gene CTD PMID:29154799 Fn3k Rat vancomycin increases expression ISO Fn3k (Mus musculus) 6480464 Vancomycin results in increased expression of FN3K mRNA CTD PMID:18930951
(+)-schisandrin B (EXP) 1,1-dichloroethene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-tribromophenol (ISO) 3,3',4,4'-tetrachlorobiphenyl (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-chloropropane-1,2-diol (EXP) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) aflatoxin B1 (ISO) alpha-Zearalanol (EXP) amitrole (EXP) aristolochic acid A (ISO) arsenite(3-) (ISO) benzo[a]pyrene (ISO) Benzo[k]fluoranthene (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) cadmium dichloride (EXP) carbon nanotube (ISO) chlorpyrifos (ISO) cisplatin (ISO) clofibrate (ISO) cobalt atom (EXP) cobalt dichloride (EXP) Cuprizon (EXP) decabromodiphenyl ether (ISO) diquat (ISO) ethanol (ISO) flutamide (EXP) furan (EXP) glycidyl methacrylate (ISO) indole-3-methanol (EXP) iron atom (EXP) iron(0) (EXP) ketamine (EXP) leflunomide (EXP) lipopolysaccharide (ISO) mercury dichloride (EXP) methimazole (EXP) N-nitrosodiethylamine (ISO) N-Nitrosopyrrolidine (ISO) nickel atom (EXP) nickel dichloride (EXP) nitrofen (EXP) oxaliplatin (EXP) ozone (ISO) p-toluidine (EXP) paracetamol (ISO) paraquat (EXP) perfluorooctanoic acid (EXP) permethrin (ISO) pirinixic acid (EXP,ISO) pregnenolone 16alpha-carbonitrile (ISO) propanal (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) silicon dioxide (ISO) sodium tungstate (EXP) Soman (EXP) sulfadimethoxine (EXP) sunitinib (ISO) tetrachloromethane (EXP,ISO) tetraphene (ISO) thioacetamide (EXP) titanium dioxide (EXP,ISO) topotecan (EXP) trichloroethene (EXP,ISO) tungsten (EXP) valproic acid (ISO) vancomycin (ISO)
Fn3k (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 107,198,566 - 107,214,176 (+) NCBI GRCr8 mRatBN7.2 10 106,700,670 - 106,715,903 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 106,700,670 - 106,715,895 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 111,803,227 - 111,818,592 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 111,266,283 - 111,281,648 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 106,621,074 - 106,636,294 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 110,626,462 - 110,642,262 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 110,631,494 - 110,642,260 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 110,212,251 - 110,227,799 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 110,664,291 - 110,674,692 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 10 105,166,933 - 105,251,709 (+) NCBI Celera Cytogenetic Map 10 q32.3 NCBI
FN3K (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 82,735,615 - 82,751,196 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 82,735,615 - 82,751,196 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 80,693,491 - 80,709,072 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 78,286,797 - 78,302,362 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 78,286,796 - 78,302,362 NCBI Celera 17 77,288,245 - 77,303,864 (+) NCBI Celera Cytogenetic Map 17 q25.3 NCBI HuRef 17 76,093,495 - 76,108,595 (+) NCBI HuRef CHM1_1 17 80,779,666 - 80,795,298 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 83,610,119 - 83,625,854 (+) NCBI T2T-CHM13v2.0
Fn3k (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 121,325,779 - 121,341,316 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 121,325,739 - 121,341,317 (+) Ensembl GRCm39 Ensembl GRCm38 11 121,434,953 - 121,450,490 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 121,434,913 - 121,450,491 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 121,296,267 - 121,311,804 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 121,251,058 - 121,286,099 (+) NCBI MGSCv36 mm8 Celera 11 133,170,968 - 133,186,426 (+) NCBI Celera Cytogenetic Map 11 E2 NCBI cM Map 11 85.38 NCBI
Fn3k (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955506 434,613 - 448,894 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955506 434,613 - 451,063 (-) NCBI ChiLan1.0 ChiLan1.0
FN3K (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 99,280,187 - 99,296,404 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 104,183,634 - 104,199,915 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 77,154,014 - 77,169,903 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 82,950,967 - 82,966,161 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 82,950,967 - 82,966,161 (+) Ensembl panpan1.1 panPan2
FN3K (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Dog10K_Boxer_Tasha 9 333,964 - 342,778 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 325,704 - 334,583 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 325,717 - 334,660 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 319,869 - 328,677 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 481,098 - 489,948 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 556,376 - 565,219 (-) NCBI UU_Cfam_GSD_1.0
Fn3k (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
FN3K (Sus scrofa - pig)
FN3K (Chlorocebus sabaeus - green monkey)
Fn3k (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 36 Count of miRNA genes: 34 Interacting mature miRNAs: 36 Transcripts: ENSRNOT00000054915 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 12880384 Cm107 Cardiac mass QTL 107 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 90404397 107211142 Rat 12880385 Cm108 Cardiac mass QTL 108 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 90404397 107211142 Rat 1354641 Bvd2 Brain ventricular dilatation QTL 2 6.36 0.001 brain ventricle morphology trait (VT:0000822) hydrocephalus severity score (CMO:0001881) 10 93223816 107057807 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 2303589 Bw87 Body weight QTL 87 2 body mass (VT:0001259) body weight (CMO:0000012) 10 81285008 107211142 Rat 12880396 Am13 Aortic mass QTL 13 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 10 90404397 107211142 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 12880398 Kidm67 Kidney mass QTL 67 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 10 90404397 107211142 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 12880395 Cm109 Cardiac mass QTL 109 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 10 90404397 107211142 Rat 1579915 Bp280 Blood pressure QTL 280 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 90404397 107211142 Rat 61396 Bp9 Blood pressure QTL 9 4.8 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68420376 107211142 Rat 2298548 Neuinf7 Neuroinflammation QTL 7 3.4 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 10 72224939 107211142 Rat 1302404 Cia27 Collagen induced arthritis QTL 27 2.6 0.0045 joint integrity trait (VT:0010548) experimental arthritis severity measurement (CMO:0001459) 10 76452683 107211142 Rat 2317754 Glom25 Glomerulus QTL 25 3.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 82685200 107211142 Rat 634320 Niddm49 Non-insulin dependent diabetes mellitus QTL 49 4.41 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 10 88539139 107211142 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 10450498 Bp384 Blood pressure QTL 384 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67750049 107211142 Rat 4889492 Pancm2 Pancreatic morphology QTL 2 3.2 pancreatic beta cell morphology trait (VT:0005217) ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814) 10 76748906 107211142 Rat 6893366 Bw106 Body weight QTL 106 0.3 0.47 body mass (VT:0001259) body weight (CMO:0000012) 10 70199100 107211142 Rat 10450493 Bp382 Blood pressure QTL 382 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 94759759 107211142 Rat 1578672 Bmd16 Bone mineral density QTL 16 6.2 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 96703043 107057807 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2293646 Bss25 Bone structure and strength QTL 25 10.96 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 10 69738412 107211142 Rat 2300172 Bmd57 Bone mineral density QTL 57 9.8 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 10 69738412 107211142 Rat 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 2.38 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 72224939 107211142 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 61363 Oia3 Oil induced arthritis QTL 3 0.001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 87307617 107211142 Rat 2292438 Bp311 Blood pressure QTL 311 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 76246085 107211142 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2292436 Bp310 Blood pressure QTL 310 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 94759759 107211142 Rat 724530 Bp149 Blood pressure QTL 149 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 90627439 107211142 Rat 1300137 Bp186 Blood pressure QTL 186 3.57 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 10 90627439 107057807 Rat 631538 Oia5 Oil induced arthritis QTL 5 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 87055121 107211142 Rat 1642980 Bp300 Blood pressure QTL 300 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68383129 107211142 Rat 2293663 Bss33 Bone structure and strength QTL 33 9.34 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 10 69738412 107211142 Rat 1578663 Bss18 Bone structure and strength QTL 18 3.6 femur width (VT:1000666) femoral neck width (CMO:0001695) 10 96703043 107057807 Rat
RH135080
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 106,714,577 - 106,715,678 (+) MAPPER mRatBN7.2 Rnor_6.0 10 110,640,937 - 110,642,037 NCBI Rnor6.0 Rnor_5.0 10 110,226,474 - 110,227,574 UniSTS Rnor5.0 RGSC_v3.4 10 110,673,369 - 110,674,469 UniSTS RGSC3.4 Celera 10 105,250,386 - 105,251,486 UniSTS Cytogenetic Map 10 q32.3 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
54
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000054915 ⟹ ENSRNOP00000051798
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 106,700,670 - 106,715,895 (+) Ensembl Rnor_6.0 Ensembl 10 110,631,494 - 110,642,260 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000103390 ⟹ ENSRNOP00000089005
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 106,700,722 - 106,715,895 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000105585 ⟹ ENSRNOP00000097152
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 106,700,670 - 106,708,591 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000118691 ⟹ ENSRNOP00000095420
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 106,700,670 - 106,706,390 (+) Ensembl
RefSeq Acc Id:
NM_001109051 ⟹ NP_001102521
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 107,198,952 - 107,214,176 (+) NCBI mRatBN7.2 10 106,700,670 - 106,715,896 (+) NCBI Rnor_6.0 10 110,631,494 - 110,642,260 (+) NCBI Rnor_5.0 10 110,212,251 - 110,227,799 (+) NCBI RGSC_v3.4 10 110,664,291 - 110,674,692 (+) RGD Celera 10 105,166,933 - 105,251,709 (+) RGD
Sequence:
CAGTCAGGCATCAAAGCTTGGAGAACAGATGGCAGATTTGCACCTTTACAACCAGAAACTCAGGGAGAAGTCCAAGGCTCAGCAGAACACAGTGGGCTGTGGGGCGGAGGATGCTGAGCCCCGGGGTG TGACCAAGTTCGGCTTTCACACAGTGACGTGCTGTGGCTTCATCCCACAGGTGAATGAATGGCAGGATGACTGGCCAACCTTTTTCACTCGACATCGGCTCCAAGCTCAGTTGGATCTCATAGAAAAG GACTATGCTGACCGAGAGACACAAGAACTGTGGTCAAGGCTACAGGTGAAGATCCCAGAGCTGTTTTCTGGTATAGAGATTGTCCCTGCCCTGCTCCATGGAGACCTCTGGTCTGGAAACGTGGCTGA GGATGAGCAGGGCCCCATTATTTATGACCCAGCCTCCTTCTACGGCCATTCTGAGTTTGAACTGGCAATTGCATCGATGTTTGGGGGGTTCCCCAGATCCTTCTTCACTGCCTACCATCAGAAGATCC CAAAGGCTCCAGGGTTCGACAAACGCCTGCTGCTCTACCAGCTCTTTAACTACCTAAACCATTGGAACCACTTTGGGCGGGAGTATAGAAGCCCATCCCTGGGGATGATGAGGAAACTGCTCAGGTAG CAGAGGGCTGGACCTAATAAAACGTCAAACTGGATCTCT
hide sequence
RefSeq Acc Id:
XM_039086651 ⟹ XP_038942579
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 107,198,566 - 107,206,394 (+) NCBI mRatBN7.2 10 106,700,744 - 106,708,590 (+) NCBI
RefSeq Acc Id:
XM_039086652 ⟹ XP_038942580
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 107,198,570 - 107,209,778 (+) NCBI mRatBN7.2 10 106,700,744 - 106,709,329 (+) NCBI
RefSeq Acc Id:
XM_063269673 ⟹ XP_063125743
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 107,199,378 - 107,214,176 (+) NCBI
RefSeq Acc Id:
NP_001102521 ⟸ NM_001109051
- UniProtKB:
D3ZZU8 (UniProtKB/TrEMBL)
- Sequence:
MADLHLYNQKLREKSKAQQNTVGCGAEDAEPRGVTKFGFHTVTCCGFIPQVNEWQDDWPTFFTRHRLQAQLDLIEKDYADRETQELWSRLQVKIPELFSGIEIVPALLHGDLWSGNVAEDEQGPIIYD PASFYGHSEFELAIASMFGGFPRSFFTAYHQKIPKAPGFDKRLLLYQLFNYLNHWNHFGREYRSPSLGMMRKLLR
hide sequence
Ensembl Acc Id:
ENSRNOP00000051798 ⟸ ENSRNOT00000054915
RefSeq Acc Id:
XP_038942580 ⟸ XM_039086652
- Peptide Label:
isoform X3
RefSeq Acc Id:
XP_038942579 ⟸ XM_039086651
- Peptide Label:
isoform X2
- UniProtKB:
A0A8I6AW19 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSRNOP00000095420 ⟸ ENSRNOT00000118691
Ensembl Acc Id:
ENSRNOP00000097152 ⟸ ENSRNOT00000105585
Ensembl Acc Id:
ENSRNOP00000089005 ⟸ ENSRNOT00000103390
RefSeq Acc Id:
XP_063125743 ⟸ XM_063269673
- Peptide Label:
isoform X1
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-03-04
Fn3k
fructosamine 3 kinase
Fnsk_predicted
similar to fructosamine-3-kinase (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2006-03-07
Fnsk_predicted
similar to fructosamine-3-kinase (predicted)
Fnsk
similar to fructosamine-3-kinase
Symbol and Name status set to approved
1299863
APPROVED
2006-02-09
Fnsk
similar to fructosamine-3-kinase
Symbol and Name status set to provisional
70820
PROVISIONAL